Diabetes related autoimmunity in gestational diabetes mellitus: Is it important?

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 9, 2009, Pages 674-682

  Lapolla, A ^a   Dalfra M G ^a   Fedele, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Autoimmunity; Diabetes; Pregnancy

Indexed keywords

AUTOIMMUNITY; FEMALE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; RISK FACTOR;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; HUMANS; ISLETS OF LANGERHANS; PREGNANCY; RISK FACTORS;

EID: 70350569925     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.04.004     Document Type: Review

References (97)

1. Metzger B.E., and Coustan D.R. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. The Organizing Committee. Diabetes Care 21 Suppl. 2 (1998) B161-B167
2. Corrado F., D'Anna R., Cannata M.L., Caputo F., Rizzo P., Cannizzaro D., et al. Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy. Nutr Metab Cardiovasc Dis 16 1 (2006) 79-80
3. Kjos S.L., and Buchanan T.A. Gestational diabetes mellitus. N Engl J Med 341 23 (1999) 1749-1756
4. Lencioni C., Volpe L., Miccoli R., Cuccuru I., Chatzianagnostou K., Ghio A., et al. Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. Nutr Metab Cardiovasc Dis 16 7 (2006) 485-493
5. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 10 (2002) 1862-1868
6. Mauricio D., Balsells M., Morales J., Corcoy R., Puig-Domingo M., and de Leiva A. Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus. Diabetes Metab Rev 12 4 (1996) 275-285
7. Nerup J., Mandrup-Poulsen T., Helqvist S., Andersen H.U., Pociot F., Reimers J.I., et al. On the pathogenesis of IDDM. Diabetologia 37 Suppl. 2 (1994) S82-S89
8. Ordovas J.M. Editorial. Nutr Metab Cardiovasc Dis 17 (2007) 71-73
9. Ziegler A.G., Hummel M., Schenker M., and Bonifacio E. Autoantibody appearance and risk for the development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 48 3 (1999) 460-468
10. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., and Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59 4 (1996) 1134-1148
11. Tait B.D., Harrison L.C., Drummond B.P., Stewart V., Varney M.D., and Honeyman M.C. HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum Immunol 42 2 (1995) 116-122
12. Sanjeevi C.B. Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults. Ann N Y Acad Sci 1079 (2006) 67-80
13. Lohmann T., Sessler J., Verlohren H.J., Schröder S., Rötger J., Dahn K., et al. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20 4 (1997) 524-529
14. Van der Auwera B., Van Waeyenberge C., Schuit F., Heimberg H., Vandewalle C., Gorus F., et al. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Belgian Diabetes Registry. Diabetes 44 5 (1995) 527-530
15. Gambelunghe G., Kockum I., Bini V., De Giorgi G., Celi F., Betterle C., et al. Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease. Diabetes 54 (2005) 900-905
16. Dorner G., Plagemann A., and Reinagel H. Familial diabetes aggregation in type 1 diabetics: gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring. Exp Clin Endocrinol 89 2 (1987) 84-90
17. Bell D.S., Banger B.O., Go R.C., Goldenberg R.L., Perkins L.L., Vanichanan C.J., et al. Risk factors for gestational diabetes in black population. Diabetes Care 13 11 (1990) 1196-1201
18. Stangenberg M., Agarwal N., Rahman F., Sheth K., al Sedeiry S., and De Vol E. Frequency of HLA genes and islet antibodies (ICA) and result of postpartum oral glucose tolerance tests (OGTT) in Saudi Arabian women with abnormal OGTT during pregnancy. Diabetes Res 14 1 (1990) 9-13
19. Damm P., Kuhl C., Buschard K., Jakobsen B.K., Svejgaard A., Sodoyez-Goffaux F., et al. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 11 6 (1994) 558-563
20. Vambergue A., Fajardy I., Bianchi F., Cazaubiel M., Verier-Mine O., Goeusse P., et al. Gestational diabetes mellitus and HLA class II (-DQ, -DR) association: the Digest Study. Eur J Immunogenet 24 5 (1997) 385-394
21. Shaat N., Ekelund M., Lernmark A., Ivarsson S., Nilsson A., Perfekt R., et al. Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia 47 5 (2004) 878-884
22. Rubinstein P., Walker M., Krassner J., Carrier C., Carpenter C., Dobersen MJ., et al. HLA antigens and islet cell antibodies in gestational diabetes. Hum Immunol 3 3 (1981) 271-275
23. Freinkel N., Metzger B.E., Phelps R.L., Dooley S.L., Ogata E.S., Radvany R.M., et al. Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion. HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34 Suppl. 2 (1985) 1-7
24. Ferber K.M., Keller E., Albert E.D., and Ziegler A.G. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 84 7 (1999) 2342-2348
25. Lapolla A., Betterle C., Sanzari M., Zanchetta R., Pfeifer E., Businaro A., et al. An immunological and genetic study of patients with gestational diabetes mellitus. Acta Diabetol 33 2 (1996) 139-144
26. Ide A., Babu S.R., Robles D.T., Wang T., Erlich H.A., Bugawan T.L., et al. "Extendent" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk. Diabetes 54 6 (2005) 1879-1883
27. Torn C., Gupta M., Sanjeevi C.B., Aberg A., Frid A., and Ladin-Olsson M. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population. Hum Immunol 65 12 (2004) 1443-1450
28. Steinborn A., Saran G., Schneider A., Fersis N., Sohn C., and Schmitt E. The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol 56 2 (2006) 124-134
29. Oztekin O. New insights into the pathophysiology of gestational diabetes mellitus: possible role of human leukocyte antigen-G. Med Hypotheses 69 3 (2007) 526-530
30. Kuhnert M., Strohmeier R., Stengmuller M., and Halberstandt E. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 76 2 (1998) 147-151
31. Watanabe M., Iwatani Y., Kaneda T., Hidaka Y., Mitsuda N., Morimoto Y., et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 37 5 (1997) 368-377
32. Honeyman M.C., Brusic V., Stone N.L., and Harrison L.C. Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol 16 10 (1998) 966-969
33. Santamaria P., Lewis C., Jessurun J., Sutherland D.E.R., and Barbosa J.J. Skewed T-cell receptor usage and junctional heterogeneity among isletitis αβ and γδ T-cells in human IDDM [corrected]. Diabetes 43 4 (1994) 599-606
34. Petersen L.D., Duinkerken G., Bruining G.J., van Lier R.A., de Vries R.R., and Roep B.O. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9 6 (1996) 731-737
35. Roep B.O. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46 3 (2003) 305-321
36. Di Mario U., Dotta F., Gargiulo P., Sutherland J., Andreani D., Guy K., et al. Immunology in diabetic pregnancy: activated T-cells in diabetic mothers and neonates. Diabetologia 30 2 (1987) 66-71
37. Bompiani G.D., Galluzzo A., Giordano C., Botta R.M. T lymphocyte subset phenotypes in diabetic pregnant women and their infants. Immunology in Diabetes 84 International Symposium, Rome, 15-17 March 1984;15.
38. Lapolla A., Sanzari M., Betterle C., Dalfrà M.G., Masin M., Zanchetta R., et al. Evaluation of T-cell receptor CD3+γδ in gestational diabetes mellitus. Acta Diabetol 37 4 (2000) 207-211
39. Lapolla A., Dalfrà M.G., Sanzari M., Fedele D., Betterle C., Masin M., et al. Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine 31 4 (2005) 280-287
40. Lang F.P., Schatz D.A., Pollock B.H., Riley W.J., MacLaren N.K., Dumont-Driscoll M., et al. Increased T lymphocytes bearing the gamma/delta T cell receptor in subjects at high risk for insulin dependent diabetes. J Autoimmun 4 6 (1991) 925-933
41. Delovitch T., and Sing B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7 6 (1998) 727-738
42. Lapolla A., Sanzari M.C., Zancanaro F., Masin M., Guerrieo A., Piva I., et al. A study on lymphomonocyte subpopulations in diabetic mothers at delivery and in their newborn. Diabetes Nutr Metab 12 6 (1999) 394-399
43. Mahmoud F., Abul H., Omu A., and Haines D. Lymphocyte sub-populations in gestational diabetes. Am J Reprod Immunol 53 1 (2005) 21-29
44. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., and Jackson R.A. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA 512bdc/IA-2 autoantibodies. Diabetes 45 7 (1996) 926-933
45. Vandewalle C.G., Falorni A., Svanholm S., Lernmark A., Pipeleers D.G., and Gorus F.K. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab 80 3 (1995) 846-851
46. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104 43 (2007) 17040-17045
47. Ginsberg-Fellner F., Mark E.M., Nechemias C., Hausknecht R.U., Rubinstein P., Dobersen M.J., et al. Islet cell antibodies in gestational diabetes. Lancet 2 8190 (1980) 362-363
48. Steel J.M., Irvine W.J., and Clarke B.F. The significance of pancreatic islet cell antibody and abnormal glucose tolerance during pregnancy. J Clin Lab Immunol 4 2 (1980) 83-85
49. Fallucca F., Di Mario U., Gargiulo P., Iavicoli M., Galfo C., Contreas G., et al. Humoral immunity in diabetic pregnancy: interrelationships with maternal/neonatal complications and maternal metabolic control. Diabete Metab 11 6 (1985) 387-395
50. Stowers J.M., Sutherland H.W., and Kerridge D.F. Long-range implications for the mother. The Aberdeen experience. Diabetes 34 Suppl. 2 (1985) 106-110
51. Catalano P.M., Tyzbir E.D., and Sims E.A. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13 5 (1990 May) 478-482
52. Mauricio D., Corcoy R., Codina M., Balsells M., Puig Domingo M., Pou J.M., et al. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes mellitus shortly after pregnancy. Diabetes Nutr Metab 5 (1992) 237-241
53. Dozio N., Beretta A., Belloni C., Castiglioni M., Rosa S., Bosi E., et al. Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus. Diabetes Care 20 1 (1997) 81-83
54. Fuchtenbusch M., Ferber K., Standl E., and Ziegler A.G. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 46 9 (1997) 1459-1467
55. Whittingham S., Byron S.L., Tuomilehto J., Zimmet P.Z., Myers M.A., Vidgren G., et al. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women. Diabet Med 14 8 (1997) 678-685
56. Panczel P., Kulkey O., Luczay A., Bornemisza B., Illyes G., Halmos T., et al. Detection of antibodies against pancreatic islet cells in clinical practice. Orv Hetil 140 148 (1999) 2695-2701
57. Kinalski M., Kretowski A., Telejko B., Kowalska I., Bingley P., and Kinalska I. Prevalence of ICA antibodies, anti-GAD and anti-IA2 in women with gestational diabetes treated with diet. Przegl Lek 56 5 (1999) 342-346
58. Bartha J.L., Martinez-del-Fresno P., and Comino-Delgado R. Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy. Am J Obstet Gynecol 184 5 (2001) 965-970
59. Lapolla A., Fedele D., Pedini B., Dal Fra M.G., Sanzari M., Masin M., et al. Low frequency of autoantibodies to islet cell, glutamic acid decarboxylase and second-islet antigen in patients with gestational diabetes mellitus: a follow-up study. Ann N Y Acad Sci 958 (2002) 263-266
60. Albareda M., Caballero A., Badell G., Piquer S., Ortiz A., de Leiva A., et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26 4 (2003) 1199-1205
61. Bo S., Menato G., Pinach S., Signorile A., Bardelli C., Lezo A., et al. Clinical characteristics and outcome of pregnancy in women with gestational hyperglycemia with and without antibodies to beta-cell antigens. Diabet Med 20 1 (2003) 64-68
62. Järvelä I., Juutinen J., Koskela P., Hartikainen A.L., Kulmala P., Knip M., et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 29 3 (2006) 607-612
63. Ivarsson S.A., Ackefors M., Carlsson A., Ekberg G., Falorni A., Kockum I., et al. Glutamate decarboxylase antibodies in non-diabetic pregnancy precedes insulin-dependent diabetes in the mother but not necessarily in the offspring. Autoimmunity 26 4 (1997) 261-269
64. Murgia C., Orrù M., Portoghese E., Garau N., Zedda P., Berria R., et al. Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report. Reprod Biol Endocrinol 6 (2008) 24-30
65. Naserke H.E., Dozio N., Ziegler A.G., and Bonifacio E. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41 6 (1998) 681-683
66. Tuomilehto J., Zimmet P., Mackay I.R., Koskela P., Vidgren G., Toivanen L., et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343 8910 (1994 Jun 4) 1383-1385
67. Beischer N.A., Wein P., Sheedy M.T., Mackay I.R., Rowley M.J., and Zimmet P. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Am J Obstet Gynecol 173 5 (1995 Nov) 1563-1569
68. Petersen J.S., Dyrberg T., Damm P., Kuhl C., Molsted-Petersen L., and Buschard K. GAD65 autoantibodies in women with gestational or insulin-dependent diabetes mellitus diagnosed during pregnancy. Diabetologia 39 11 (1996) 1329-1333
69. Fallucca F., Tiberti C., Torresi P., Cardellini G., Sciullo E., D'Aliberti T., et al. Autoimmune markers of diabetes in diabetic pregnancy. Ann Ist Super Sanita 33 3 (1997) 425-428
70. Mitchell M.L., Hermos R.J., Larson C.A., Palomaki G.E., and Haddow J.E. Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care 23 11 (2000) 1705-1706
71. Kousta E., Lawrence N.J., Anyaoku V., Johnston D.G., and McCarthy M.I. Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groups. BJOG 108 7 (2001) 716-720
72. Weng J., Ekelund M., Lehto M., Li H., Ekberg G., Frid A., et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25 1 (2002) 68-71
73. Balaji M., Shtauvere-Brameus A., Balaji V., Seshiah V., and Sanjeevi C.B. Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens. Ann N Y Acad Sci 958 (2002 Apr) 281-284
74. Füchtenbusch M., Bonifacio E., Lampasona V., Knopff A., and Ziegler A.G. Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol 135 2 (2004) 318-321
75. Damanhouri L.H., Dromey J.A., Christie M.R., Narsrat H.A., Ardawi S.M., Robins R.A., et al. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Diabet Med 22 4 (2005) 448-452
76. Ferraz T.B., Motta R.S., Capibaribe D.M., Ferraz C.L., Chacra A., Forti A.C., et al. Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes. Diabetes Res Clin Pract 78 1 (2007) 141-142
77. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222 4630 (1983) 1337-1339
78. Mayrhofer M., Rabin D.U., Messenger L., Standl E., and Ziegler A.G. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp Clin Endocrinol Diabetes 104 3 (1996) 228-234
79. Löbner K., Knopff A., Baumgarten A., Mollenhauer U., Marienfeld S., and Garrido-Franco M. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55 3 (2006) 792-797
80. Lauenborg J., Hansen T., Jensen D.M., Vestergaard H., Molsted-Pedersen L., Hornnes P., et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27 5 (2004) 1194-1199
81. Corcoy R., Mauricio D., and de Leiva A. Diabetes-related antibodies and pregnancy. In: Djelmis J., Desoye G., and Ivanisevic M. (Eds). "Diabetology of pregnancy": frontiers in diabetes vol. 17 (2005), Karger, Basel 195-205
82. Nilsson C., Ursing D., Torn C., Aberg A., and Landin-Olsson M. Presence of GAD Antibodies during gestational diabetes predicts type 1 diabetes. In: Buyon J.P., Nelson J.L., and Lockshin M.D. (Eds). The effect of pregnancy on autoimmune diseases. Diabetes Care 30 (2007) 1968-1971
83. Gale E.A.M. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48 2 (2005) 2195-2199
84. Tuomi T., Groop L.C., Zimmer P.Z., Rowley M., Knowles W., and MacKay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42 2 (1993) 359-362
85. Horton V., Stratton I., Bottazzo G.F., Shattock M., Mackay I., Zimmet P., et al. Genetic heterogeneity of autoimmune diabetes: age at presentation in adult is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 42 5 (1999) 608-616
86. Turner R., Stratton I., Horton V., Manley S., Zimmet P., Mackay I.R., et al. UKPDS 25: autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350 9087 (1997) 1288-1293
87. Bosi E., Garancini M.P., Poggiali F., Bonifacio E., and Gallus G. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of Northern Italy. Diabetologia 42 7 (1999) 840-844
88. Genovese S., Bazzigaluppi E., Goncalves D., Ciucci A., Cavallo M.G., Purrello F., et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 154 3 (2006) 441-447
89. Fourlanos S., Perry C., Stein M.S., Stankovich J., Harrison L.C., and Colman P.G. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 29 5 (2006) 970-975
90. Ola T.O., Gigante A., and Leslie D. Latent autoimmune diabetes of adults (LADA). Nutr Metab Cardiovasc Dis 16 3 (2006) 163-167
91. Pozzilli P., and Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24 8 (2001) 1460-1467
92. Buzzetti R., Di Pietro S., Giaccari A., Petrone A., Locatelli M., Suraci C., et al. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30 4 (2007) 932-938
93. Falorni A., Gambelunghe G., Forini F., Kassi G., Cosentino A., Candeloro P., et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 85 1 (2000) 309-316
94. Tiberti C., Giordano C., Locatelli M., Bosi E., Bottazzo G.F., Buzzetti R., et al. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes 57 5 (2008) 1276-1283
95. Mauricio D., Corcoy R., Codina M., Morales J., Balsells M., and de Leiva A. Islet cell antibodies and beta cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects. Diabet Med 12 11 (1995) 1009-1014
96. Vauhkonen I., Niskanen L., Knip M., Ilonen J., Vanninen E., Kainulainen S., et al. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes in adults. Diabetologia 43 1 (2000) 69-78
97. de Leiva A., Mauricio D., and Corcoy R. Diabetes-related autoantibodies and gestational diabetes. Diabetes Care 30 Suppl. 2 (2007 Jul) S127-S133